Treatment for otitis media

Comment

Mathieu Lemaire. CMAJ. 2005.

. 2005 Aug 2;173(3):235; author reply 236.

doi: 10.1503/cmaj.1050050.

No abstract available

Comment on

A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age.
Le Saux N, Gaboury I, Baird M, Klassen TP, MacCormick J, Blanchard C, Pitters C, Sampson M, Moher D. Le Saux N, et al. CMAJ. 2005 Feb 1;172(3):335-41. doi: 10.1503/cmaj.1040771. CMAJ. 2005. PMID: 15684116 Free PMC article. Clinical Trial.

1. Le Saux N, Gaboury I, Baird M, Klassen TP, MacCormick J, Blanchard C, et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. CMAJ 2005;172(3):335-41. - PMC - PubMed
1. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods [published erratum appears in BMJ 1996; 313(7056):550]. BMJ 1996;313(7048):36-9. - PMC - PubMed
1. Gomberg-Maitland M, Frison L, Halperin JL. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality. Am Heart J 2003;146(3):398-403. - PubMed
1. Chen G, Wang YC, Chi GY. Hypotheses and type I error in active-control noninferiority trials. J Biopharm Stat 2004;14(2):301-13. - PubMed